Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Comment by Vegas63on Apr 11, 2021 9:19am
198 Views
Post# 32973953

RE:Here’s the links to answer all questions

RE:Here’s the links to answer all questions Yes Cane that is correct about the new Tilray stock  being converted to TSX 

here is  what I found  ;

Next month, Aphria Inc. (APHA.TO) (APHA) will hold a special shareholder meeting to vote on the previously announced merger with Tilray, Inc. (TLRY)

This has been a hot topic of discussion and the market has responded favorably to the potential mega-merger. We believe the combined company will have an attractive portfolio of  international cannabis assets and expect it to have a larger market share of Canada’s medical and recreational industry, once the deal is complete.

Another topic that we have been asked about the transaction is related to what Canadian Aphria shareholders will receive as part of the agreement. Since Tilray will be the surviving entity of the merger, its symbol will not change when the merger is completed. 

Tilray is not like every other Canadian Licensed Producer (LP) and is the only one to trade exclusively on the Nasdaq. When compared to companies like Canopy Growth Corporation (WEED.TO) (CGC) or Aurora Cannabis Inc. (ACB.TO) (ACB), which trade in both Canada and the US, Tilray only has a US symbol. 

We believe that the landscape of the legal cannabis industry is changing rapidly and the structure of the Aphria-Tilray merger to highlight how much the industry has evolved. Going forward, we expect to see an increased focus on the US market from Canadian LPs and expect operators to follow a strategy that is similar to Tilray. 

In regards to the Tilray-Aphria merger, we expect Tilray to have a Canadian symbol on the Toronto Stock Exchange (TSX) before the transaction is completed. We are bullish on the growth prospects that are associated with the Tilray-Aphria merger agreement and believe that our readers need to be aware of the opportunity. 



<< Previous
Bullboard Posts
Next >>